RANIBIZUMAB

UNII:	ZL1R02VT79
Type:	INGREDIENT SUBSTANCE
Formula:
Preferred Substance Name:	RANIBIZUMAB
GSRS Full Record:	ZL1R02VT79 i

347396-82-1
BYOOVIZ
CIMERLI
FAB-12 VARIANT Y0317
FYB-201
FYB201
NUFYMCO
PF-582
PF-582 (RANIBIZUMAB BIOSIMILAR)
PF582
RANIBIZUMAB BIOSIMILAR PF582
RANIBIZUMAB [EMA EPAR]
RANIBIZUMAB [JAN]
RANIBIZUMAB [MART.]
RANIBIZUMAB [MI]
RANIBIZUMAB [PURPLE BOOK CDER]
RANIBIZUMAB [USAN]
RANIBIZUMAB [VANDF]
RANLUSPEC
RBZ
RG-3645
RHUFAB
Ranibizumab
Ranibizumab [WHO-DD]
Ranibizumab eqrn [WHO-DD]
Ranibizumab nuna [WHO-DD]
Ranibizumab-EQRN
Ranibizumab-HKDZ
Ranibizumab-LEYK
Ranibizumab-NUNA
SUSVIMO
immunoglobulin G1, anti-(human vascular endothelial growth factor) Fab fragment (human-mouse monoclonal rhuFAB V2 1-chain), disulfide with human-mouse monoclonal rhuFAB V2 light chain
ranibizumab [INN]

Note

UNIIs are generated based on scientific identity characteristics using ISO 11238 data elements. UNII availability does not imply any regulatory review or approval. Synonyms and mappings are based on the best public information available at the time of publication. Please report any problems/errors associated with this data to FDA-SRS@fda.hhs.gov.

RANIBIZUMAB

Synonyms and Mappings

Resources